X0306 4 2021-01-19 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2021-01-19 4 M 0 5000 12.21 A 5000 D Common Stock 2021-01-19 4 S 0 334 121.59 D 4666 D Common Stock 2021-01-19 4 S 0 1300 122.72 D 3366 D Common Stock 2021-01-19 4 S 0 1000 123.57 D 2366 D Common Stock 2021-01-19 4 S 0 1666 124.72 D 700 D Common Stock 2021-01-19 4 S 0 700 125.57 D 0 D Stock Option (Right to Buy) 12.21 2021-01-19 4 M 0 5000 0 D 2027-10-03 Common Stock 5000 179952 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.99 to $121.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.09 to $123.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $123.13 to $123.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.28 to $125.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $125.29 to $126.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 229,358 of the options will vest over 4 years (25% on the first anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 137,614 of the options will vest over 5 years (25% on the second anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). 91,743 of the options will vest over 6 years (25% on the third anniversary of the grant date of October 3, 2017, then quarterly for the next 3 years). /s/ Lori Henderson, as Attorney-in-Fact 2021-01-20